BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 32185604)

  • 1. Evaluating the implementation of cervical cancer screening programs in low-resource settings globally: a systematized review.
    Dykens JA; Smith JS; Demment M; Marshall E; Schuh T; Peters K; Irwin T; McIntosh S; Sy A; Dye T
    Cancer Causes Control; 2020 May; 31(5):417-429. PubMed ID: 32185604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical cancer screening decentralized policy adaptation: an African rural-context-specific systematic literature review.
    Rahman R; Clark MD; Collins Z; Traore F; Dioukhane EM; Thiam H; Ndiaye Y; De Jesus EL; Danfakha N; Peters KE; Komarek T; Linn AM; Linn PE; Wallner KE; Charles M; Hasnain M; Peterson CE; Dykens JA
    Glob Health Action; 2019; 12(1):1587894. PubMed ID: 30938248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementing community-based cervical cancer screening programs using visual inspection with acetic acid in India: A systematic review.
    Adsul P; Manjunath N; Srinivas V; Arun A; Madhivanan P
    Cancer Epidemiol; 2017 Aug; 49():161-174. PubMed ID: 28704717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing high risk HPV-based primary screening for cervical cancer in low- and middle-income countries: opportunities and challenges.
    Pimple SA; Mishra GA
    Minerva Ginecol; 2019 Oct; 71(5):365-371. PubMed ID: 31698891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer screening - The challenges of complete pathways of care in low-income countries: Focus on Malawi.
    Cubie HA; Campbell C
    Womens Health (Lond); 2020; 16():1745506520914804. PubMed ID: 32364058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global strategies for cervical cancer prevention.
    Pimple S; Mishra G; Shastri S
    Curr Opin Obstet Gynecol; 2016 Feb; 28(1):4-10. PubMed ID: 26642063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical cancer screening and prevention in low-resource settings.
    Bradford L; Goodman A
    Clin Obstet Gynecol; 2013 Mar; 56(1):76-87. PubMed ID: 23337844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-level scale-up of cervical cancer prevention services in a low-resource setting: development, implementation, and evaluation of the cervical cancer prevention program in Zambia.
    Parham GP; Mwanahamuntu MH; Kapambwe S; Muwonge R; Bateman AC; Blevins M; Chibwesha CJ; Pfaendler KS; Mudenda V; Shibemba AL; Chisele S; Mkumba G; Vwalika B; Hicks ML; Vermund SH; Chi BH; Stringer JS; Sankaranarayanan R; Sahasrabuddhe VV
    PLoS One; 2015; 10(4):e0122169. PubMed ID: 25885821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Training health care providers to administer VIA as a screening test for cervical cancer: a systematic review of essential training components.
    Brevik TB; da Matta Calegari LR; Mosquera Metcalfe I; Laake P; Maza M; Basu P; Todd A; Carvalho AL
    BMC Med Educ; 2023 Sep; 23(1):712. PubMed ID: 37770904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative assessment of test characteristics of cervical cancer screening methods for implementation in low-resource settings.
    Asgary R; Beideck E; Naderi R
    Prev Med; 2022 Jan; 154():106883. PubMed ID: 34785209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for cancer in low- and middle-income countries.
    Sankaranarayanan R
    Ann Glob Health; 2014; 80(5):412-7. PubMed ID: 25512156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screen-and-treat approach to cervical cancer prevention using visual inspection with acetic acid and cryotherapy: experiences, perceptions, and beliefs from demonstration projects in Peru, Uganda, and Vietnam.
    Paul P; Winkler JL; Bartolini RM; Penny ME; Huong TT; Nga le T; Kumakech E; Mugisha E; Jeronimo J
    Oncologist; 2013; 18 Suppl():6-12. PubMed ID: 24334477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical cancer in developing countries: effective screening and preventive strategies with an application in Rwanda.
    Mukakalisa I; Bindler R; Allen C; Dotson J
    Health Care Women Int; 2014; 35(7-9):1065-80. PubMed ID: 24750113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cancer screening in high- and low-resource countries: implications and new developments.
    Hoppenot C; Stampler K; Dunton C
    Obstet Gynecol Surv; 2012 Oct; 67(10):658-67. PubMed ID: 23112073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community-Based Screening for Cervical Cancer Using Visual Inspection With Acetic Acid: Results and Lessons Learned From a Pilot Study in Vietnam.
    Vu LTH; Tran HTD; Nguyen BT; Bui HTT; Nguyen AD; Pham NB
    J Public Health Manag Pract; 2018; 24 Suppl 2():S3-S8. PubMed ID: 29369251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acting on the call for cervical cancer elimination: Planning tools for low- and middle- income countries to increase the coverage and effectiveness of screening and treatment.
    Herrick T; Thomson KA; Shin M; Gannon S; Tsu V; de Sanjosé S
    BMC Health Serv Res; 2022 Oct; 22(1):1246. PubMed ID: 36241993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innovative approaches to cervical cancer screening in low- and middle-income countries.
    Toliman PJ; Kaldor JM; Tabrizi SN; Vallely AJ
    Climacteric; 2018 Jun; 21(3):235-238. PubMed ID: 29488817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cervical cancer screening in rural Madagascar: Feasibility, coverage and incidence].
    Dumont A; Bessières N; Benbassa A; Razafindrafara G; Rabearison F; Philippe HJ
    J Gynecol Obstet Hum Reprod; 2017 Apr; 46(4):327-332. PubMed ID: 28643659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based screening, early diagnosis and treatment strategy of cervical cancer for national policy in low- resource countries: example of India.
    Saxena U; Sauvaget C; Sankaranarayanan R
    Asian Pac J Cancer Prev; 2012; 13(4):1699-703. PubMed ID: 22799391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs.
    Zhao D; Zhang L; Xie F; Peng D; Wei J; Jiang L; Zhang S; Qi D
    BMC Cancer; 2020 Aug; 20(1):810. PubMed ID: 32847541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.